Philip Rackliffe - Jul 1, 2024 Form 3 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, Ultrasound & IGT
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
3
Date filed
7/1/2024, 04:05 PM
Next filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GEHC Common Stock, par value $0.01 per share 13.1K Jul 1, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GEHC Employee Stock Option (right to buy) Jul 1, 2024 Common Stock, par value $0.01 per share 7.84K $70.01 Direct F3
holding GEHC Employee Stock Option (right to buy) Jul 1, 2024 Common Stock, par value $0.01 per share 4.63K $75.30 Direct F4
holding GEHC Employee Stock Option (right to buy) Jul 1, 2024 Common Stock, par value $0.01 per share 3.83K $92.72 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of awards of: (i) 9,217 restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, granted on September 1, 2022, of which 50% will vest on September 1, 2024 and 50% will vest on September 1, 2025; (ii) 892 restricted stock units with respect to GE HealthCare common stock, granted on February 1, 2023, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026; (iii) 1,660 restricted stock units with respect to GE HealthCare common stock, granted on March 1, 2023, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026; and (iv) 1,348 restricted stock units with respect to GE HealthCare common stock, granted on March 1, 2024, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.
F5 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027.

Remarks:

Exhibit 24.1 - Power of Attorney